Advertisement
Advertisement
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
17.00
USDSponsored
+0.63
+3.85%
Jun 24, 16:00 UTC -4
Closed
After-Market
17.00
0.00
+0.03%
AMLX Earnings Reports
Positive Surprise Ratio
AMLX beat 8 of 18 last estimates.
44%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.37
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/-19.57%
Amylyx Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On May 07, 2026, AMLX reported earnings of -0.37 USD per share (EPS) for Q1 26, missing the estimate of -0.33 USD, resulting in a -9.82% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.35% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.37 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Amylyx Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Amylyx Pharmaceuticals, Inc. Common Stock reported EPS of -$0.37, missing estimates by -9.82%, and revenue of $0.00, 0% as expectations.
How did the market react to Amylyx Pharmaceuticals, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -5.35%, changed from $16.06 before the earnings release to $15.20 the day after.
When is Amylyx Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Amylyx Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 6
analysts, Amylyx Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement